Outpace Bio
Chelsea Dunmire is a Research Associate at Outpace Bio since September 2022, with prior experience as a Research Scientist 1 at UW Medicine, where research focused on the host immune response, gut microbiome, and enteric pathogens in a BSL-2 laboratory. Chelsea's expertise includes optimizing laboratory protocols, developing in vitro co-culture models, and utilizing machine learning for analyzing gene expression and virulence factors. Chelsea has a strong foundation in microbiology and molecular biology from California Lutheran University, where responsibilities included tutoring, lecturing on bioinformatics, and conducting research on the gut microbiome of California sea lions. Chelsea's background also includes a STEM research fellowship at the University of Aberdeen and leadership experience in university event planning and public health initiatives.
This person is not in any teams
Outpace Bio
Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety.It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacyand safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.